These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23185385)

  • 1. Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy.
    Thakur GA; Sengupta SM; Grizenko N; Choudhry Z; Joober R
    PLoS One; 2012; 7(11):e49616. PubMed ID: 23185385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.
    Shang CY; Chiang HL; Gau SS
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():89-96. PubMed ID: 25554436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
    Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Hong SB; Cho SC; Shin MS; Yoo HJ
    Behav Brain Funct; 2010 Oct; 6():57. PubMed ID: 20929549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder.
    Song J; Song DH; Jhung K; Cheon KA
    Int Clin Psychopharmacol; 2011 Mar; 26(2):107-13. PubMed ID: 21127421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy.
    Choudhry Z; Sengupta SM; Grizenko N; Fortier ME; Thakur GA; Bellingham J; Joober R
    J Child Psychol Psychiatry; 2012 Aug; 53(8):892-902. PubMed ID: 22486528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype.
    Sengupta SM; Grizenko N; Thakur GA; Bellingham J; DeGuzman R; Robinson S; TerStepanian M; Poloskia A; Shaheen SM; Fortier ME; Choudhry Z; Joober R
    J Psychiatry Neurosci; 2012 Feb; 37(2):129-37. PubMed ID: 22297068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD.
    Thakur GA; Grizenko N; Sengupta SM; Schmitz N; Joober R
    BMC Psychiatry; 2010 Jun; 10():50. PubMed ID: 20569447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).
    Ramoz N; Boni C; Downing AM; Close SL; Peters SL; Prokop AM; Allen AJ; Hamon M; Purper-Ouakil D; Gorwood P
    Neuropsychopharmacology; 2009 Aug; 34(9):2135-42. PubMed ID: 19387424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
    Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
    J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of SNAP-25, SLC6A2, and LPHN3 with OROS methylphenidate treatment response in attention-deficit/hyperactivity disorder.
    Song J; Kim SW; Hong HJ; Lee MG; Lee BW; Choi TK; Lee SH; Yook KH
    Clin Neuropharmacol; 2014; 37(5):136-41. PubMed ID: 25229170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.
    Park S; Kim JW; Yang YH; Hong SB; Park MH; Kim BN; Shin MS; Yoo HJ; Cho SC
    Behav Brain Funct; 2012 May; 8():22. PubMed ID: 22591463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study.
    Fageera W; Sengupta SM; Labbe A; Grizenko N; Joober R
    Neuromolecular Med; 2018 Dec; 20(4):515-524. PubMed ID: 30051166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit/hyperactivity disorder.
    Park MH; Kim JW; Yang YH; Hong SB; Park S; Kang H; Kim BN; Shin MS; Yoo HJ; Cho SC
    Neurosci Lett; 2012 Apr; 514(2):159-63. PubMed ID: 22405810
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Naumova D; Grizenko N; Sengupta SM; Joober R
    World J Biol Psychiatry; 2019 Jul; 20(6):486-495. PubMed ID: 29182037
    [No Abstract]   [Full Text] [Related]  

  • 17. Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.
    Cho SC; Kim BN; Cummins TD; Kim JW; Bellgrove MA
    J Psychopharmacol; 2012 Mar; 26(3):380-9. PubMed ID: 21628343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.
    Renner TJ; Nguyen TT; Romanos M; Walitza S; Röser C; Reif A; Schäfer H; Warnke A; Gerlach M; Lesch KP
    Atten Defic Hyperact Disord; 2011 Sep; 3(3):285-9. PubMed ID: 21739117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of a rare protective allele in the noradrenaline transporter gene and ADHD.
    Xu X; Hawi Z; Brookes KJ; Anney R; Bellgrove M; Franke B; Barry E; Chen W; Kuntsi J; Banaschewski T; Buitelaar J; Ebstein R; Fitzgerald M; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Gill M; Asherson P
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1564-7. PubMed ID: 18937296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample.
    Cho SC; Kim JW; Kim BN; Hwang JW; Park M; Kim SA; Cho DY; Yoo HJ; Chung US; Son JW; Park TW
    Neuropsychobiology; 2008; 57(3):131-8. PubMed ID: 18552510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.